Seroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United States.
Adolescent
Adult
Aged
Antibodies, Neutralizing
/ blood
Antibodies, Viral
/ blood
Australia
/ epidemiology
Child
Child, Preschool
Cross-Sectional Studies
Disease Outbreaks
Female
Humans
Infant
Male
Middle Aged
Netherlands
/ epidemiology
Parechovirus
/ immunology
Picornaviridae Infections
/ epidemiology
Seroepidemiologic Studies
United States
/ epidemiology
Young Adult
Australia
Picornaviruses
United States
neutralizing antibody
outbreak
parechovirus A3
seroepidemiology
seroprevalence
the Netherlands
viruses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
entrez:
19
12
2018
pubmed:
19
12
2018
medline:
16
7
2019
Statut:
ppublish
Résumé
Recent parechovirus A3 (PeV-A3) outbreaks in Australia suggest lower population immunity compared with regions that have endemic PeV-A3 circulation. A serosurvey among populations in the Netherlands, the United States, and Australia before and after the 2013 Australia outbreak showed high PeV-A3 neutralizing antibody prevalence across all regions and time periods, indicating widespread circulation.
Identifiants
pubmed: 30561318
doi: 10.3201/eid2501.180352
pmc: PMC6302606
doi:
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
148-152Références
Emerg Infect Dis. 2015 Nov;21(11):1966-72
pubmed: 26485714
J Gen Virol. 2012 Nov;93(Pt 11):2363-2370
pubmed: 22837420
J Pediatric Infect Dis Soc. 2018 May 15;7(2):104-112
pubmed: 28369502
Sci Rep. 2017 Mar 14;7:44423
pubmed: 28290509
Microbiol Immunol. 2016 Dec;60(12):854-858
pubmed: 27925289
Pediatr Infect Dis J. 2018 Dec;37(12):1304-1308
pubmed: 30382954
Curr Opin Infect Dis. 2010 Jun;23(3):224-30
pubmed: 20414971
Epidemiol Infect. 2016 Dec;144(16):3451-3460
pubmed: 27571735
J Clin Virol. 2013 Sep;58(1):211-5
pubmed: 23891146
J Virol. 2015 Aug;89(15):7457-64
pubmed: 25948742
Euro Surveill. 2014 Nov 20;19(46):
pubmed: 25425513
Sci Rep. 2017 Sep 21;7(1):12075
pubmed: 28935894
J Gen Virol. 2010 May;91(Pt 5):1229-38
pubmed: 20089803
J Gen Virol. 2004 Feb;85(Pt 2):391-398
pubmed: 14769896